Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Randomized, Single-dose, Two Sequence, Two-period, Crossover Study to Assess the Bioequivalence of Cariprazine 1.5 mg Hard Capsule in Vocarzine (Test) in Comparison With Reagila® (Reference) Under Fasting Conditions

NCT07121868 is registered in ClinicalTrials.gov with Aya Mohammed Abdel Magid Abdel Hamid as lead sponsor.

NCT NCT07121868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07121868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Randomized, Single-dose, Two Sequence, Two-period, Crossover Study to Assess the Bioequivalence of Cariprazine 1.5 mg Hard Capsule in Vocarzine (Test) in Comparison With Reagila® (Reference) Under Fasting Conditions
Lead sponsor
Aya Mohammed Abdel Magid Abdel Hamid
Phase
Phase 1
Overall status
Completed
Start date
August 3, 2024
Completion date
January 23, 2025
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bioequivalence study in healthy subjects